The REVERSE-HF study is a randomized controlled trial to evaluate clinical outcomes of adjustable ultrafiltration with the Aquadex System as compared to adjustable IV loop diuretics in patients with worsening heart failure (HF) and fluid overload.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
372
ultrafiltration
diuretics
Banner Health
Tucson, Arizona, United States
RECRUITINGTime to first heart failure (HF) event
Heart Failure (HF) event defined as any HF rehospitalization or unplanned use of IV loop diuretics, vasoactive medications or Aquadex therapy in any outpatient setting.
Time frame: within 30 days
Win ratio analysis
Win ratio analysis of cardiovascular (CV) mortality, HF events and quality of life
Time frame: within 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
MemorialCare, Long Beach Medical Center
Long Beach, California, United States
Sharp Memorial Hospital, San Diego Cardiac Center
San Diego, California, United States
RECRUITINGUniversity of California San Francisco
San Francisco, California, United States
WITHDRAWNBayCare Medical Group, Morton Plant
Clearwater, Florida, United States
COMPLETEDSt. Joseph's Hospital
Tampa, Florida, United States
WITHDRAWNUniversity of Kentucky
Lexington, Kentucky, United States
RECRUITINGHenry Ford Health
Detroit, Michigan, United States
RECRUITINGMount Sinai Morningside
New York, New York, United States
RECRUITINGThe Mount Sinai Hospital
New York, New York, United States
RECRUITING...and 7 more locations